Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gibbs

Showing results (221-230 of 234) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry|August 10, 2013
Spectroscopic, computational modeling and cytotoxicity of a series of meso-phenyl and meso-thienyl-BODIPYsJaime H Gibbs, Larry T Robins, Zehua Zhou, et al.
British Journal of Experimental Pathology|December 1, 1988
Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in manJ S Beck, S M Morley, J G Lowe, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1981
The effect of strenuous physical exercise on circulating blood lymphocytes and serum cortisol levelsA J Robertson, K C Ramesar, R C Potts, et al.
Lancet (London, England)|August 25, 1979
Cimetidine and the immune responseA J Robertson, N R Peden, J H Saunders, et al.
Gut|May 1, 1982
Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidineN R Peden, A J Robertson, E J Boyd, et al.
Clinical and Experimental Immunology|June 1, 1986
The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin AJ S Beck, S M Morley, J H Gibbs, et al.
Pharmacotherapy|September 19, 2001
Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion programA J Taylor, K Grace, J Swiecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I resultsF A Holmes, V Valero, R S Walters, et al.
Archives of Dermatology|March 21, 2012
Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regionsEsther de Vries, Rita Micallef, David H Brewster, et al.
Vaccine|July 31, 1998
Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaquesB E Ivins, M L Pitt, P F Fellows, et al.
Pageof 24

Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|August 10, 2013
Spectroscopic, computational modeling and cytotoxicity of a series of meso-phenyl and meso-thienyl-BODIPYsJaime H Gibbs, Larry T Robins, Zehua Zhou, et al.
British Journal of Experimental Pathology|December 1, 1988
Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in manJ S Beck, S M Morley, J G Lowe, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1981
The effect of strenuous physical exercise on circulating blood lymphocytes and serum cortisol levelsA J Robertson, K C Ramesar, R C Potts, et al.
Lancet (London, England)|August 25, 1979
Cimetidine and the immune responseA J Robertson, N R Peden, J H Saunders, et al.
Gut|May 1, 1982
Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidineN R Peden, A J Robertson, E J Boyd, et al.
Clinical and Experimental Immunology|June 1, 1986
The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin AJ S Beck, S M Morley, J H Gibbs, et al.
Pharmacotherapy|September 19, 2001
Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion programA J Taylor, K Grace, J Swiecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I resultsF A Holmes, V Valero, R S Walters, et al.
Archives of Dermatology|March 21, 2012
Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regionsEsther de Vries, Rita Micallef, David H Brewster, et al.
Vaccine|July 31, 1998
Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaquesB E Ivins, M L Pitt, P F Fellows, et al.
Pageof 24